👥 Risk, Representation, Reality: Rethinking CVD Research for 2 Billion South Asian Lives

🧬 South Asians make up 25% of the world—yet just 3% of major cardiovascular trials. A new systematic review (310 RCTs, 1M+ participants) reveals stark underrepresentation, especially outside India. No South Asians in trials for heart failure, cardiac arrest, or valvular disease. 📉 The data gap is real—and it's limiting care.   🔍 We need global trial designs that are inclusive, disaggregated, and powered for equity. Let's change the research playbook. 💡   #CardioTrials #SouthAsianHealth #DiversityInResearch #PrecisionMedicine #GlobalHealth 🌏🫀📊